For medication-specific comparisons, see Retatrutide vs Tirzepatide and Retatrutide vs Semaglutide
For patients, that means the conversation shouldnt begin with whether BPC-157 is simply safe or unsafe. A better question is what the current evidence tells us, where the gaps in our knowledge remain, and whether BPC-157 is appropriate for your individual circumstances
Patients using non-oral contraceptive methods (intrauterine devices, implants, injections, patches, or vaginal rings) are not affected by these absorption concerns, as these methods do not rely on gastrointestinal absorption
Since DSIP is not FDA-approved, its long-term safety, purity, and dosing are uncertain
Miracle Hair Mask (8.45 fl oz.)
Patients already on other medications should disclose them during consultation to screen for interactions